Ovarian cancer is the deadliest type of cancer affecting the female reproductive system. While surgery and chemotherapy are commonly used to treat it, many patients experience a recurrence of the disease that no longer responds to treatment. Immunotherapy—a method that helps the body’s immune system fight cancer—has worked well in other cancers but not in […]

Big Sisters of BC Lower Mainland is a nonprofit organization dedicated to enabling life-changing mentoring relationships for self-identified girls, non-binary, trans, and Two Spirit youth. The organization is committed to building confidence, self-esteem, and a sense of belonging for its mentees through a variety of programs and a strong emphasis on justice, equity, diversity, and […]

Fraser Health Authority is one of the largest regional health systems in Canada, delivering hospital and community-based services to nearly two million people across Metro Vancouver and the Fraser Valley. As part of its commitment to “Better health, best in health care,” Fraser Health is undertaking a significant digital transformation within its Housekeeping Services portfolio […]

In 2020, there were 19.3 million new cancer cases and 9.9 million related deaths, with 70% occurring in low- and middle-income countries. In Latin America, cancer remains a leading cause of mortality, with cases projected to rise from 4 million in 2020 to 6 million by 2040. Indigenous populations are among the most affected; in […]

This research project will identify and quantify the cumulative impacts of human development and land use in Alberta’s Crowsnest Watershed using satellite imagery collected over time and geospatial change detection techniques. By analyzing how the landscape has changed over time as a result of human use, and incorporating relevant local and community-sourced data, the study […]

Les chondrosarcomes extra-squelettiques sont des tumeurs rares dont le traitement repose principalement sur la chirurgie. Toutefois, l’ajout d’une radiothérapie avant l’opération (radiothérapie néo-adjuvante) pourrait aider à réduire la taille de la tumeur et faciliter son retrait. Ce projet de recherche vise à mieux comprendre les bénéfices et les risques de cette approche en comparant des […]

Tick-borne diseases, including Lyme disease and Anaplasmosis, are an increasing public health concern in Canada, with rising case numbers driven by climate change and expanding tick populations. Current testing methods are limited as they typically detect only one pathogen at a time and often miss early-stage infections. As a result, many Canadians can go undiagnosed […]

This project is aimed at assisting the NS Health Innovation Hub (hereinafter referred to as the Hub) in the delivery of its mandate to “solve critical health challenges for the benefit of all Nova Scotians. One way the Hub delivers on this mandate is through what it calls the ‘test & try portfolio’ – an […]

The GeneSight (GS) Psychotropic Test (AssureRx Health, Inc.) measures individual variations in drug-related genes and recommends optimal drug choices for individual patients. A clinical study will be conducted to validate novel gene markers of antipsychotic-induced weight gain for use in an enhanced version of GS. Sarah Groleau will be responsible for genotyping DNA from 600 […]

Chaque signalement à la DPJ suit une trajectoire comprenant plusieurs étapes : le traitement initial du signalement, l’évaluation de la compromission ou non de l’enfant, l’orientation vers des mesures afin de mettre fin à la situation de compromission (e.g., mesures volontaires, judiciaires), leur application et puis une révision qui permet de modifier ou d’étendre l’application […]

The GeneSight (GS) Psychotropic Test (AssureRx Health, Inc.) measures individual variations in drug-related genes and recommends optimal drug choices for individual patients. A clinical study will be conducted to validate novel gene markers of antipsychotic-induced weight gain for use in an enhanced version of GS. Sarah Groleau will be responsible for genotyping DNA from 600 […]

Les gouvernements, hôpitaux et banques détiennent d’immenses volumes de données précieuses, mais les lois strictes sur la confidentialité et les risques de sécurité rendent toute collaboration presque impossible, freinant l’innovation et limitant la performance des modèles d’IA. De ce fait, les hôpitaux ne peuvent pas bénéficier de modèles de diagnostic partagés et entrainés par plusieurs […]